IPAR Stock Analysis: Inter Parfums | NASDAQ
Household & Personal Products | NASDAQ, USA | Market Cap: 3.690m USD | 12M Return: 23.2% | US4583341098 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.8M
EPS Trend: 70.5%
Qual. Beats: -1
Rev. Trend: 94.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Inter Parfums, Inc. (NASDAQ: IPAR) is a US-headquartered fragrance company that manufactures, markets, and distributes perfumes and fragrance-related products globally through two operating segments: European Based Operations and United States Based Operations. Founded in 1982 and originally named Jean Philippe Fragrances (renamed in July 1999), the company is based in New York and operates within the Personal Care Products sub-industry of consumer staples.
The companys portfolio is built largely on a licensing model, holding agreements with luxury and fashion houses including Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, Longchamp, Off-White, and Van Cleef & Arpels, alongside brands such as Abercrombie & Fitch, Donna Karan/DKNY, Ferragamo, GUESS, Hollister, MCM, Oscar de la Renta, and Roberto Cavalli. Distribution spans department stores, perfumeries, specialty retailers, duty-free shops, domestic and international wholesalers, and e-commerce platforms-reflecting the prestige fragrance industrys reliance on selective retail and travel retail channels alongside direct-to-consumer digital sales.
- New brand licenses and renewals drive European segment growth
- Travel retail recovery boosts duty-free fragrance demand
- US segment scales with Abercrombie and Hollister licensed brands
| Net Income: 167.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 6.33 > 1.0 |
| NWC/Revenue: 44.19% < 20% (prev 44.83%; Δ -0.63% < -1%) |
| CFO/TA 0.17 > 3% & CFO 256.1m > Net Income 167.8m |
| Net Debt (-27.2m) to EBITDA (296.0m): -0.09 < 3 |
| Current Ratio: 3.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.0m) vs 12m ago -0.38% < -2% |
| Gross Margin: 63.82% > 18% (prev 64.52%; Δ -0.70% > 0.5%) |
| Asset Turnover: 98.41% > 50% (prev 93.41%; Δ 5.00% > 0%) |
| Interest Coverage Ratio: 39.87 > 6 (EBIT TTM 271.4m / Interest Expense TTM 6.81m) |
| A: 0.45 (Total Current Assets 951.0m - Total Current Liabilities 287.3m) / Total Assets 1.49b |
| B: 0.56 (Retained Earnings 838.6m / Total Assets 1.49b) |
| C: 0.18 (EBIT TTM 271.4m / Avg Total Assets 1.53b) |
| D: 2.18 (Book Value of Equity 870.5m / Total Liabilities 399.4m) |
| Altman-Z'' = 8.24 = AAA |
| DSRI: 0.99 (Receivables 310.8m/306.2m, Revenue 1.50b/1.46b) |
| GMI: 1.01 (GM 64.52% / 63.82%) |
| AQI: 0.98 (AQ_t 0.23 / AQ_t-1 0.23) |
| SGI: 1.03 (Revenue 1.50b / 1.46b) |
| TATA: -0.06 (NI 167.8m - CFO 256.1m) / TA 1.49b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of October 29, 2026, the stock is trading at USD 114.24 with a total of 189,957 shares traded. Over the past week, the price has changed by +0.92%, over one month by -3.14%, over three months by -9.88% and over the past year by +23.16%.
Current recommended Stop Loss: 108.40 (which is 5.1% or 1.9 ATR below the current price).
Inter Parfums has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold IPAR.
- StrongBuy: 2
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 126.5 | 10.7% |
P/E Trailing = 21.9886
P/E Forward = 22.2717
P/S = 2.4573
P/B = 4.0743
P/EG = 3.1987
Revenue TTM = 1.50b USD
EBIT TTM = 271.4m USD
EBITDA TTM = 296.0m USD
Long Term Debt = 96.5m USD (from longTermDebt, last quarter)
Short Term Debt = 55.3m USD (from shortTermDebt, last quarter)
Debt = 184.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 19.2m
Net Debt = -27.2m USD (calculated: Debt 184.1m - CCE 211.3m)
Enterprise Value = 3.66b USD (3.69b + Debt 184.1m - CCE 211.3m)
Interest Coverage Ratio = 39.87 (Ebit TTM 271.4m / Interest Expense TTM 6.81m)
EV/FCF = 14.84x (Enterprise Value 3.66b / FCF TTM 246.9m)
FCF Yield = 6.74% (FCF TTM 246.9m / Enterprise Value 3.66b)
FCF Margin = 16.44% (FCF TTM 246.9m / Revenue TTM 1.50b)
Net Margin = 11.17% (Net Income TTM 167.8m / Revenue TTM 1.50b)
Gross Margin = 63.82% ((Revenue TTM 1.50b - Cost of Revenue TTM 543.4m) / Revenue TTM)
Gross Margin QoQ = 65.54% (prev 65.13%)
Tobins Q-Ratio = 2.46 (Enterprise Value 3.66b / Total Assets 1.49b)
Interest Expense / Debt = 3.70% (Interest Expense 6.81m / Debt 184.1m)
Taxrate = 23.20% (62.1m / 267.7m)
NOPAT = 208.4m (EBIT 271.4m * (1 - 23.20%))
Current Ratio = 3.31 (Total Current Assets 951.0m / Total Current Liabilities 287.3m)
Debt / Equity = 0.21 (Debt 184.1m / totalStockholderEquity, last quarter 870.5m)
Debt / EBITDA = -0.09 (Net Debt -27.2m / EBITDA 296.0m)
Debt / FCF = -0.11 (Net Debt -27.2m / FCF TTM 246.9m)
Total Stockholder Equity = 875.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.99% (Net Income 167.8m / Total Assets 1.49b)
RoE = 19.15% (Net Income TTM 167.8m / Total Stockholder Equity 875.9m)
RoCE = 27.91% (EBIT 271.4m / Capital Employed (Equity 875.9m + L.T.Debt 96.5m))
RoIC = 17.62% (NOPAT 208.4m / Invested Capital 1.18b)
WACC = 6.78% (E(3.69b)/V(3.87b) * Re(6.98%) + D(184.1m)/V(3.87b) * Rd(3.70%) * (1-Tc(0.23)))
Discount Rate = 6.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.53 | Cagr: -0.33%
[DCF] Terminal Value 77.97% ; FCFF base≈212.0m ; Y1≈243.1m ; Y5≈357.7m
[DCF] Fair Price = 168.9 (EV 5.38b - Net Debt -27.2m = Equity 5.41b / Shares 32.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 70.50 | EPS CAGR: 5.73% | SUE: -0.86 | # QB: -1
Revenue Correlation: 94.66 | Revenue CAGR: 5.70% | SUE: 0.18 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.89 | Chg30d=+0.00% | Revisions=+17% | Analysts=3
EPS current Year (2026-12-31): EPS=4.89 | Chg30d=-0.04% | Revisions=-25% | GrowthEPS=-6.7% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=5.20 | Chg30d=-0.04% | Revisions=-25% | GrowthEPS=+6.4% | GrowthRev=+7.2%
[Analyst] Revisions Ratio: -12% (up=2, down=3)